Drug-induced hypersensitivity syndrome due to carbamazepine associated with reactivation of human herpesvirus 7

Dermatology

Volumn 211, Issue 2, 2005, Pages 159-161

  Hara, Hiroyuki ^a   Kobayashi, Maiko ^a   Yokoyama, Ai ^a   Tochigi, Mizuki ^a   Matsunaga, Akie ^a   Shimizu, Hidenao ^a   Goshima, Junko ^a   Suzuki, Hiroyuki ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Carbamazepine; Human herpesvirus 7 (HHV 7); Hypersensitivity syndrome

Indexed keywords

CARBAMAZEPINE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; EPILEPSY; HUMAN; HUMAN HERPESVIRUS 7; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS REACTIVATION;

CARBAMAZEPINE; DNA, VIRAL; DRUG HYPERSENSITIVITY; EPILEPSY; FOLLOW-UP STUDIES; HERPESVIRUS 7, HUMAN; HUMANS; MALE; MIDDLE AGED; PATCH TESTS; POLYMERASE CHAIN REACTION; PREDNISOLONE; RECURRENCE; RISK ASSESSMENT; ROSEOLOVIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX;

EID: 23844535548     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086449     Document Type: Article

References (13)

1. Tas S, Simonart T: Management of drug rash with eosinophilia and systemic symptoms (DRESS): An update. Dermatology 2003;206:353-356.
2. Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, Hashimoto K: Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998;134:1113-1117.
3. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T: Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998;134:1108-1112.
4. Zeller A, Schaub N, Steffen I, Battegay E, Hirsch HH, Bircher AJ: Drug hypersensitivity syndrome to carbamazepine and human herpes virus 6 infection: Case report and literature review. Infection 2003;31:254-256.
5. Aihara M, Sugita Y, Takahashi S, et al: Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br J Dermatol 2001;144:1231-1234.
6. Descamps V, Mahe E, Houhou N, Abramowits L, Rosenberg F, Ranger-Rogez S, Crickx B: Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003;148:1032-1034.
7. Frenkel N, Schirmer EC, Wyatt LS, Katsafanas G, Roffman E, Danovich R, June CH: Isolation of a new herpesvirus from human CD4+ T cells. Proc Natl Acad Sci USA 1990;87:748-752.
8. Yamanishi K, Okuno T, Shiraki K, et al: Identification of human herpesvirus 6 as a causal agent for exanthem subitum. Lancet 1988;i:1065-1067.
9. Wyatt LS, Rodriguez WJ, Balachandran N, et al: Human herpesvirus 7: Antigenic properties and prevalence in children and adults. J Virol 1991;65:6260-6265.
10. Berneman ZN, Dharam VA, Ge L, et al: Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci USA 1992;89:10552-10556.
11. Tanaka K, Kondo T, Torigoe S, Okada S, Mukai T, Yamanishi K: Human herpesvirus 7: Another causal agent for roseola (exanthem subitum). J Pediatr 1994;125:1-5.
12. Katsafanas GC, Schirmae EC, Wyatt LS, Frenkel N: In vitro activation of human herpesvirses 6 and 7 from latency. Proc Natl Acad Sci USA 1996;93:9788-9792.
13. Le Cleach L, Fillet AM, Agut H, Chosidow O: Human herpesviruses 6 and 7: New roles yet to be discovered. Arch Dermatol 1998;134:1155-1157.